Drug name - Patanase

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7977376 NOVARTIS Olopatadine formulations for topical nasal administration Feb, 2023

(3 months from now)

US8399508

(Pediatric)

NOVARTIS Olopatadine formulations for topical nasal administration Mar, 2023

(5 months from now)

US7977376

(Pediatric)

NOVARTIS Olopatadine formulations for topical nasal administration Aug, 2023

(9 months from now)

More Information on Dosage
Strength Dosage Availability
0.665MG/SPRAY SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.